FDA Inspection 1097964 — BioAgilytix
The FDA completed an inspection of BioAgilytix on June 7, 2019 in Hamburg. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 7, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hamburg (Germany)
Additional Details
Bioanalytical BA/BE